Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics | Zendy

Georgios Tsivgoulis | Zendy; Andrei V. Alexandrov | Zendy; Jason J. Chang | Zendy; Vijay K. Sharma | Zendy; Steven L. Hoover | Zendy; Annabelle Y. Lao | Zendy; Wei Liu | Zendy; Elefterios Stamboulis | Zendy; Anne W. Alexandrov | Zendy; Marc Malkoff | Zendy; James L. Frey | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics

Author(s) -

Georgios Tsivgoulis,

Andrei V. Alexandrov,

Jason J. Chang,

Vijay K. Sharma,

Steven L. Hoover,

Annabelle Y. Lao,

Wei Liu,

Elefterios Stamboulis,

Anne W. Alexandrov,

Marc Malkoff,

James L. Frey

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.609339

Subject(s) - medicine , thrombolysis , modified rankin scale , interquartile range , stroke (engine) , emergency department , tissue plasminogen activator , intracerebral hemorrhage , fibrinolytic agent , emergency medicine , subarachnoid hemorrhage , ischemic stroke , ischemia , mechanical engineering , psychiatry , myocardial infarction , engineering

Efforts to increase the availability and shorten the time delivery of intravenous thrombolysis in patients with acute ischemic stroke carry the potential for tissue plasminogen activator administration in patients with diseases other than stroke, that is, stroke mimics (SMs). We aimed to determine safety and to describe outcomes of intravenous thrombolysis in SM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research